42 Managing The Complexities of Glucagon-Like Peptide-1 Receptor Agonist Drug Development Current and future development of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), or simply GLP-1s, involves complexities not only in formulation but in all areas of early-phase drug development
Obesity and aging are associated with altered NAD/Sirtuin 1 (SIRT1)/PARP dynamics [85]
doi: 10.1038/s41598-020-70247-z 34 LiX.BaoZ.ChenY.LanQ.SongC.ShiL.et al
As GLP-1 usage grows, interdisciplinary care becomes even more important, and RDs play a critical role
During this initial week, you might find that you cannot finish a meal that you previously would have finished entirely, or you may notice that food noisethe constant, intrusive thoughts about what to eat nextbegins to quiet down
Joe Pazona sits down with Marine vet and entrepreneur Micah Berg to discuss his personal experience with Testosterone Replacement Therapy (TRT)